Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose versus oral ferrous sulphate for postpartum iron deficiency anaemia in Nigerian women
ISRCTN51426226Phase 3Completed
- Sponsor
- University of Lagos
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral ferrous sulphate (2 arms). Started Nov 2022; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ISRCTN51426226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51426226.